Cargando...
SUMO fusion system facilitates soluble expression and high production of bioactive human fibroblast growth factor 23 (FGF23)
As a key humoral regulator of phosphate homeostasis and its involvement in the pathogenesis of human disease, human fibroblast growth factor 23 (hFGF23) has become a particularly attractive therapeutic target. To prepare soluble and bioactive recombinant human FGF23 to meet the increasing demand in...
Gardado en:
| Publicado en: | Appl Microbiol Biotechnol |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer-Verlag
2012
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7080044/ https://ncbi.nlm.nih.gov/pubmed/22249722 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00253-011-3864-4 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|